Frequency of established cardiovascular disease and its risk factors in Chinese patients with systemic lupus erythematosus

Clinical Rheumatology

Volumn 31, Issue 4, 2012, Pages 669-675

  Wang, Xiao Yang ^a   Tang, Xue Qing ^a   Huang, Ya Juan ^a   Chen, Wei Ying ^a   Yu, Xue Qing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cardiovascular disease; Prevalence; Risk factor; Systemic lupus erythematosus

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOCORTICOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEPHRITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84859779529     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1910-3     Document Type: Article

References (35)

1. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA (1976) The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60(2):221-225
2. Nikpour M, Urowitz MB, Gladman DD (2005) Premature atherosclerosis in systemic lupus erythematosus. Rheum Dis Clin North Am 31(2):329-354, vii-viii (Pubitemid 40732492)
3. Petri M, Perez-Gutthann S, Spence D, Hochberg MC (1992) Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 93(5):513-519
4. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R et al (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44(10):2331-2337 (Pubitemid 32977500)
5. Szalai AJ, Alarcon GS, Calvo-Alen J, Toloza SM, McCrory MA, Edberg JC et al (2005) Systemic lupus erythematosus in a multi-ethnic US Cohort (LUMINA). XXX: association between Creactive protein (CRP) gene polymorphisms and vascular events. Rheumatol (Oxford) 44(7):864-868 (Pubitemid 41511179)
6. Urowitz MB, Ibanez D, Gladman DD (2007) Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. J Rheumatol 34(1):70-75 (Pubitemid 46106565)
7. Bertoli AM, Vila LM, Alarcon GS, McGwin G, Edberg JC, Petri M et al (2009) Factors associated with arterial vascular events in PROFILE: a Multiethnic Lupus Cohort. Lupus 18(11):958-965
8. Gustafsson J, Gunnarsson I, Borjesson O, Pettersson S, Moller S, Fei GZ et al (2009) Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study. Arthritis Res Ther 11(6):R186
9. Manzi S, Meilahn EN, Rairie JE, Conte CG Jr, Medsger TA, Jansen-McWilliams L et al (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 145(5):408-415 (Pubitemid 27084212)
10. Anderson E, Nietert PJ, Kamen DL, Gilkeson GS (2008) Ethnic disparities among patients with systemic lupus erythematosus in South Carolina. J Rheumatol 35(5):819-825 (Pubitemid 351747122)
11. Rhew EY, Manzi SM, Dyer AR, Kao AH, Danchenko N, Barinas-Mitchell E et al (2009) Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus. Transl Res 153(2):51-59
12. Mok CC, Tang SS, To CH, Petri M (2005) Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups. Arthritis Rheum 52(9):2774-2782 (Pubitemid 41369106)
13. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725
14. Svenungsson E, Jensen-Urstad K, Heimburger M, Silveira A, Hamsten A, de Faire U et al (2001) Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 104(16):1887-1893 (Pubitemid 32983229)
15. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296-1305
16. Ong ML, Pezzetta F, Sullivan JL (1992) Cardiac abnormalities in systemic lupus erythematosus: prevalence and relationship to disease activity. Int J Cardiol 34(1):69-74
17. Burgos PI, Vila LM, Reveille JD, Alarcon GS (2009) Peripheral vascular damage in systemic lupus erythematosus: data from LUMINA, a large multi-ethnic U.S. cohort (LXIX). Lupus 18 (14):1303-1308
18. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271-1277 (Pubitemid 13221242)
19. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y et al (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17 (10):2937-2944 (Pubitemid 44484685)
20. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35(6):630-640
21. Urowitz MB, Gladman D, Ibanez D, Bae SC, Sanchez-Guerrero J, Gordon C et al (2010) Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken) 62(6):881-887
22. Toloza SM, Uribe AG Jr, McGwin G, Alarcon GS, Fessler BJ, Bastian HM et al (2004) Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum 50(12):3947-3957 (Pubitemid 39643943)
23. Yang ZJ, Liu J, Ge JP, et al. (2011). Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National diabetes and metabolic disorders study. Eur Heart J, Jun 30. doi:10.1093/eurheartj/ehr205
24. Gu Dong-feng, Huang Guang-yong, He Jiang, Wu Xi-gui, Duan Xiu-fang, Stephen MM et al (2003) Investigation of prevalence and distributing feature of chronic heart failure in Chinese adult population. Chin J Cardiol 31(1):3-6
25. Tang Xun, He Liu, Cao Yang, Wang Jin-wei, Li Na, Tian Jun et al (2011) Gender-specific differences in relative effects of cardiovascular risk factors among rural population. Beijing Da Xue Xue Bao 43(3):379-385
26. Ward MM (1999) Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 42(2):338-346
27. Manger K, Kusus M, Forster C, Ropers D, Daniel WG, Kalden JR et al (2003) Factors associated with coronary artery calcification in young female patients with SLE. Ann Rheum Dis 62(9):846-850 (Pubitemid 37026495)
28. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62 (5):707-714 (Pubitemid 8110784)
29. Hahn BH, Grossman J, Ansell BJ, Skaggs BJ, McMahon M (2008) Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther 10(4):213
30. Mok CC, Tong KH, To CH, Siu YP, Ho LY, Au TC (2007) Risk and predictors of arterial thrombosis in lupus and non-lupus primary glomerulonephritis: a comparative study. Med (Baltimore) 86 (4):203-209 (Pubitemid 47067478)
31. Bruce IN, Urowitz MB, Gladman DD, Ibanez D, Steiner G (2003) Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. Arthritis Rheum 48(11):3159-3167 (Pubitemid 37409327)
32. Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Pratt JE, Tracy RP, Kuller LH et al (2004) Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus. Arthritis Rheum 50(1):151-159 (Pubitemid 38084299)
33. Karp I, Abrahamowicz M, Fortin PR, Pilote L, Neville C, Pineau CA et al (2008) Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus? Arthritis Rheum 59 (2):169-175 (Pubitemid 351272950)
34. Valdivielso P, Gomez-Doblas JJ, Macias M, Haro-Liger M, Fernandez-Nebro A, Sanchez-Chaparro MA et al (2008) Lupus-associated endothelial dysfunction, disease activity and arteriosclerosis. Clin Exp Rheumatol 26(5):827-833
35. Mikdashi J, Handwerger B, Langenberg P, Miller M, Kittner S (2007) Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemic stroke and stroke severity in systemic lupus erythematosus. Stroke 38(2):281-285 (Pubitemid 46184295)